ASH 2018: Luspatercept Reduces Need for Blood Transfusions Among Patients With Beta-Thalassemia
Treatment cut need for blood transfusions by at least a third over 12 weeks in a majority of patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.